Diagnostik und Therapie der Akromegalie. Notwendigkeit der gezielten Überwachung von Komorbiditäten

Petersenn, S.; Christ-Crain, M.; Droste, M.; Finke, R.; Flitsch, J.; Kreitschmann-Andermahr, I.; Luger, A.; Schopohl, J. und Stalla, G. (2017): Diagnostik und Therapie der Akromegalie. Notwendigkeit der gezielten Überwachung von Komorbiditäten. In: Internist, Bd. 58, Nr. 11: S. 1171-1181

Abstract

Acromegaly is a rare and severe condition, presenting with typical signs and symptoms. The diagnosis is often initially made years after the first manifestations of the disease. In more than 99% of patients the disease is caused by a benign pituitary tumor that secretes growth hormone (GH). The diagnosis is based on the presence of increased insulin-like growth factor 1 (IGF-1) levels and a lack of GH suppression in the oral glucose tolerance test. The standard imaging procedure for tumor detection is magnetic resonance imaging in the region of the sella turcica. Treatment includes surgical, drug and radiation therapy. Important factors are an intensive aftercare of the patient, controls for detection of tumor recurrence and pituitary insufficiency as well as assessment of various organ functions and risk constellations. Patient care should involve close cooperation between endocrinologists, neurosurgeons and general practitioners as well as other specialist disciplines.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0020-9554
• Sprache: Deutsch